The FDA has documented several concerns specifically involving compounded GLP-1 products: dosing errors (including doses far exceeding the FDA-approved label), improper storage during shipping affecting medication integrity, reports of fraudulent or counterfeit compounded products, adverse event reports associated with compounded GLP-1 use, and the use of semaglutide salt forms (such as semaglutide sodium or semaglutide acetate) that should not be used for compounding
For instance, Class I drugs like acetaminophen display reduced C max in response to delayed gastric emptying
At Texas Institute of Longevity, Aesthetics & Sexual Health, we recommend that you compile a list of your overall health and weight loss concerns and symptoms prior to your first consultation and take the first step to experience for yourself the benefits of our weight loss program utilizing Wegovy with Semaglutide or any of the other GLP-1 agonists available to you
Semaglutide is generally recommended for those with a body mass index (BMI) of 30 or higher, or 27 or higher with a weight-related condition
This preserves lean muscle mass and keeps your metabolism healthy